Soluble TAM Receptor Tyrosine Kinases Correlate with Disease Severity and Predict the Early Responsiveness of Sublingual Immunotherapy in Allergic Rhinitis

References

• Abdullah B, Pawankar R, Latiff AHA, et al. Malaysian Society of Allergy and Immunology Consensus Statement on Sublingual Immunotherapy in Allergic Rhinitis. J Clin Med. 2023;12.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lan F, Zhang L. Update on pathomechanisms and treatments in allergic rhinitis. Allergy. 2022;77(11):3309–3319. doi:10.1111/all.15454
   PubMed Web of Science ®Google Scholar
• Liu P, Kang C, Zhang J, et al. The role of dendritic cells in allergic diseases. Int Immunopharmacol. 2022;113:109449. doi:10.1016/j.intimp.2022.109449
   PubMed Web of Science ®Google Scholar
• Del Cuvillo A, Santos V, Montoro J, et al. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate, and severe. Rhinology. 2017;55:34–38. doi:10.4193/Rhin16.025
   PubMed Web of Science ®Google Scholar
• Feng LL, Sun FY, Chen Y, et al. Studying the Effects of Vitamin A on the Severity of Allergic Rhinitis and Asthma. Iran J Allergy Asthm. 2021;20:684–692.
   Web of Science ®Google Scholar
• Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immun. 2017;140(4):950–958. doi:10.1016/j.jaci.2017.03.050
   PubMed Web of Science ®Google Scholar
• Roberts G, Pfaar O, Akdis CA, et al. EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73(4):765–798. doi:10.1111/all.13317
   PubMed Web of Science ®Google Scholar
• Shamji MH, Sharif H, Layhadi JA, et al. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma. J Allergy Clin Immun. 2022;149:791–801. doi:10.1016/j.jaci.2022.01.016
   PubMed Web of Science ®Google Scholar
• Han DH, Cho S, Lockey R, et al. Early Responses of specific IgE Can Predict the Outcome of House Dust Mite Sublingual Immunotherapy. J Allergy Clin Immun. 2020;145:Ab63–Ab63. doi:10.1016/j.jaci.2019.12.721
   Web of Science ®Google Scholar
• Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. Allergy. 2021;76(11):3383–3389. doi:10.1111/all.15044
   PubMed Web of Science ®Google Scholar
• Li HB, Chen S, Cheng L, et al. Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma. J Thorac Dis. 2019;11(12):4936–4950. doi:10.21037/jtd.2019.12.37
   PubMed Web of Science ®Google Scholar
• Lee CH, Chun T. Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function. Mol Cells. 2019;42(1):1–7. doi:10.14348/molcells.2018.0419
   PubMed Web of Science ®Google Scholar
• Rothlin CV, Carrera-Silva EA, Bosurgi L, et al. TAM Receptor Signaling in Immune Homeostasis. Annu Rev Immunol. 2015;33:355–391. doi:10.1146/annurev-immunol-032414-112103
   PubMed Web of Science ®Google Scholar
• Ekman C, Jonsen A, Sturfelt G, et al. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology. 2011;50(6):1064–1069. doi:10.1093/rheumatology/keq459
   PubMed Web of Science ®Google Scholar
• Grabiec AM, Denny N, Doherty JA, et al. Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma. J Allergy Clin Immunol. 2017;140(4):1144–1146 e1144. doi:10.1016/j.jaci.2017.03.024
   PubMed Web of Science ®Google Scholar
• Xia J, Li J, Deng M, et al. Diosmetin alleviates acute lung injury caused by lipopolysaccharide by targeting barrier function. Inflammopharmacology. 2023;1–11.
   Web of Science ®Google Scholar
• Zhou YD, Xu M, Gong W, et al. Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis. Mediat Inflamm. 2022;2022:1–10. doi:10.1155/2022/3378035
   Web of Science ®Google Scholar
• Zhou Y, Xu M, Gong W, et al. Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis. Mediators Inflamm. 2022;2022:3378035.
   PubMed Web of Science ®Google Scholar
• Wang H, Lin X, Hao C, et al. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients. Allergy. 2006;61(2):191–197. doi:10.1111/j.1398-9995.2005.00913.x
   PubMed Web of Science ®Google Scholar
• Zhu K, Xia C, Chen J, et al. Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients. Mediators Inflamm. 2021;2021:5576596. doi:10.1155/2021/5576596
   PubMed Web of Science ®Google Scholar
• Wu H, Zheng J, Xu S, et al. Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation. 2021;18(1):2. doi:10.1186/s12974-020-02041-7
   PubMed Web of Science ®Google Scholar
• Carrera Silva EA, Chan PY, Joannas L, et al. T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response. Immunity. 2013;39(1):160–170. doi:10.1016/j.immuni.2013.06.010
   PubMed Web of Science ®Google Scholar
• Chan PY, Carrera Silva EA, De Kouchkovsky D, et al. The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity. Science. 2016;352(6281):99–103. doi:10.1126/science.aaf1358
   PubMed Web of Science ®Google Scholar
• Colas L, Magnan A, Brouard S. Immunoglobulin E response in health and disease beyond allergic disorders. Allergy. 2022;77(6):1700–1718. doi:10.1111/all.15230
   PubMed Web of Science ®Google Scholar
• KleinJan A, Willart M, van Rijt LS, et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol. 2006;118(5):1117–1125. doi:10.1016/j.jaci.2006.05.030
   PubMed Web of Science ®Google Scholar
• Yin X, Chen S, Eisenbarth SC. Dendritic Cell Regulation of T Helper Cells. Annu Rev Immunol. 2021;39(1):759–790. doi:10.1146/annurev-immunol-101819-025146
   PubMedGoogle Scholar
• Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021;21(11):739–751. doi:10.1038/s41577-021-00538-7
   PubMed Web of Science ®Google Scholar
• Ubil E, Caskey L, Holtzhausen A, et al. Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response. J Clin Invest. 2018;128(6):2356–2369. doi:10.1172/JCI97354
   PubMed Web of Science ®Google Scholar
• Hong JY, Chung Y, Steenrod J, et al. Macrophage activation state determines the response to rhinovirus infection in a mouse model of allergic asthma. Respir Res. 2014;15(1):63. doi:10.1186/1465-9921-15-63
   PubMedGoogle Scholar
• Wang HR, Wei SZ, Song XY, et al. IL-1beta and Allergy: focusing on Its Role in Allergic Rhinitis. Mediators Inflamm. 2023;2023:1265449. doi:10.1155/2023/1265449
   PubMed Web of Science ®Google Scholar
• Kato A. Group 2 Innate Lymphoid Cells in Airway Diseases. Chest. 2019;156(1):141–149. doi:10.1016/j.chest.2019.04.101
   PubMed Web of Science ®Google Scholar
• Saradna A, Do DC, Kumar S, et al. Macrophage polarization and allergic asthma. Transl Res. 2018;191:1–14. doi:10.1016/j.trsl.2017.09.002
   PubMed Web of Science ®Google Scholar
• Lee JW, Chun W, Lee HJ, et al. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases. Cells-Basel. 2021;10.
   Google Scholar
• Drazdauskaitė G, Layhadi JA, Shamji MH. Mechanisms of Allergen Immunotherapy in Allergic Rhinitis. Curr Allergy Asthma Rep. 2020;21:2. doi:10.1007/s11882-020-00977-7
   PubMed Web of Science ®Google Scholar
• Lin Z, Liu Q, Li T, et al. The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration. Int Forum Allergy Rhinol. 2016;6(1):82–87. doi:10.1002/alr.21657
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Fukumoto S, Sugawara S. Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy. J Oral Biosci. 2019;61(2):73–77. doi:10.1016/j.job.2019.02.001
   PubMed Web of Science ®Google Scholar
• Fargen KM, Singla A, Mocco J. The New England Journal of Medicine Stroke Trials: what Do They Really Mean? Neurosurgery. 2015;62(Suppl 1):137–140. doi:10.1227/NEU.0000000000000780
   PubMedGoogle Scholar
• Yu S, Han B, Liu S, et al. Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1 (Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis. Mol Immunol. 2017;90:172–181. doi:10.1016/j.molimm.2017.07.015
   PubMed Web of Science ®Google Scholar
• Loges S, Schmidt T, Tjwa M, et al. Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6. Blood. 2010;115(11):2264–2273. doi:10.1182/blood-2009-06-228684
   PubMed Web of Science ®Google Scholar
• Lou H, Huang Y, Chu X, et al. M2 Macrophages Upregulated by Allergen Exposure in Seasonal Allergic Rhinitis. Int Arch Allergy Immunol. 2023;1–11.
   Web of Science ®Google Scholar
• Shiratori H, Feinweber C, Luckhardt S, et al. THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro. Mol Immunol. 2017;88:58–68. doi:10.1016/j.molimm.2017.05.027
   PubMed Web of Science ®Google Scholar
• Zissler UM, Schmidt-Weber CB. Predicting Success of Allergen-Specific Immunotherapy. Front Immunol. 2020;11:1826. doi:10.3389/fimmu.2020.01826
   PubMed Web of Science ®Google Scholar
• Giroud P, Renaudineau S, Gudefin L, et al. Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC. Front Immunol. 2020;11:564133. doi:10.3389/fimmu.2020.564133
   PubMed Web of Science ®Google Scholar
• Gadiyar V, Patel G, Chen J, et al. Targeted degradation of MERTK and other TAM receptor paralogs by heterobifunctional targeted protein degraders. Front Immunol. 2023;14:1135373. doi:10.3389/fimmu.2023.1135373
   PubMed Web of Science ®Google Scholar
• Xie S, Zhang H, Wang F, et al. Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite-Induced Allergic Rhinitis. Front Pharmacol. 2021;12:681724. doi:10.3389/fphar.2021.681724
   PubMed Web of Science ®Google Scholar